MGP
EXAS

Metis Global Partners’s Exact Sciences EXAS Stock Holding History

Metis Global Partners’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,687
Closed -$203K – 786
2025
Q1 		$203K Buy
4,687
+1,003
+27% +$50.8K 0.01% 730
2024
Q4 		$207K Buy
3,684
+151
+4% +$9.4K 0.01% 741
2024
Q3 		$241K Buy
+3,533
New +$199K 0.01% 703
2024
Q2 		– Sell
-3,587
Closed -$248K – 769
2024
Q1 		$248K Sell
3,587
-53
-1% -$3.35K 0.01% 682
2023
Q4 		$269K Sell
3,640
-2,979
-45% -$195K 0.01% 658
2023
Q3 		$452K Buy
6,619
+2,933
+80% +$249K 0.02% 552
2023
Q2 		$346K Buy
3,686
+159
+5% +$12.4K 0.02% 598
2023
Q1 		$239K Buy
+3,527
New +$227K 0.02% 610

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Metis Global Partners's EXAS Position: Q2 2025 in Review

Metis Global Partners sold out of Exact Sciences (EXAS) in Q2 2025, closing a stake of 4,687 shares — an estimated $203K sold.

Metis Global Partners first reported a position in EXAS in Q1 2023 and held it in 8 quarters. The position peaked at $452K in Q3 2023. 558 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

  • Metis Global Partners reported no remaining Exact Sciences position as of Q2 2025 after selling out during the quarter.
  • Metis Global Partners sold 4,687 Exact Sciences shares in Q2 2025, an estimated $203K.
  • Metis Global Partners first reported a position in Exact Sciences in Q1 2023 and held it in 8 quarters.
  • Metis Global Partners's Exact Sciences position peaked at $452K in Q3 2023.
  • 558 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on Metis Global Partners's 13F filing for Q2 2025, filed 6 Aug 2025.